SCHEMBL2149741

SCHEMBL2149741

Cc1c(C(=O)O)c2cc(=O)cc(F)c-2cn1CCC(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2148965 0.86 HDAC1 (0.31)
SCHEMBL2149199 0.83 ALDH1A1 (0.36)
SCHEMBL2149462 0.79
SCHEMBL2148940 0.79
SCHEMBL3244707 0.79 KMT2A (0.38)
SCHEMBL3236146 0.79 BRD4 (0.31)
SCHEMBL2312069 0.77 P2RY14 (0.39) PTGDR2
SCHEMBL2314611 0.75 CYP1A2 (0.36) PTGDR2
SCHEMBL2149678 0.73
SCHEMBL3230025 0.73 PTGDR2 (0.35) PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342182-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. Lundbeck A/S (DK) 2011-07-13 EP disclosed
WO-2010028655-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2010-03-18 WO disclosed